Translator Disclaimer
1 June 2002 IN VITRO DRUG SUSCEPTIBILITY PATTERN OF MYCOPLASMA ALLIGATORIS ISOLATED FROM SYMPTOMATIC AMERICAN ALLIGATORS (ALLIGATOR MISSISSIPPIENSIS)
Author Affiliations +
Abstract

A recently described mycoplasma, Mycoplasma alligatoris, was isolated from dead American alligators (Alligator mississippiensis) that had demonstrated clinical signs of lethargy, anorexia, bilateral ocular discharge, edema, paraparesis, and polyarthritis. The in vitro minimum inhibitory concentration for nine antibacterial agents was determined through serial dilution in broth and plate culture for M. alligatoris isolates. The inhibitory concentration obtained for doxycycline, enrofloxacin, sarafloxacin, oxytetracycline, tilmicosin, and tylosin (<1 μg/ml) was lower than that of clindamycin (1–8 μg/ml), chloramphenicol (8–16 μg/ml), and erythromycin (32–138 μg/ml).

Kelly E. Helmick, Daniel R. Brown, Elliott R. Jacobson, and Mary B. Brown "IN VITRO DRUG SUSCEPTIBILITY PATTERN OF MYCOPLASMA ALLIGATORIS ISOLATED FROM SYMPTOMATIC AMERICAN ALLIGATORS (ALLIGATOR MISSISSIPPIENSIS)," Journal of Zoo and Wildlife Medicine 33(2), 108-111, (1 June 2002). https://doi.org/10.1638/1042-7260(2002)033[0108:IVDSPO]2.0.CO;2
Received: 1 October 2001; Published: 1 June 2002
JOURNAL ARTICLE
4 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top